Microdosing GLP-1 is a low-dose prescription of Injectable Semaglutide
The program caps at a maximum 0.6-milligram dose of compounded semaglutide, carefully adjusted over time
In clinical studies, participants taking semaglutide GLP-1 lost more weight on average than those taking liraglutide or other GLP-1 medications
Side-Effect Tolerance GI side effects nausea, constipation, vomiting are common early on
Therefore, clinical success depends on the prerequisite of long-term persistence. Implementing target-oriented follow-up, adjusting dietary structures (small, frequent, low-fat meals), and personalizing the titration pace are often more effective in reducing early attrition than a singular focus on weight-loss metrics
This means you can burn more calories even when you're not working out